The impact of COVID-19 on familial Mediterranean fever: a nationwide study
dc.authorid | 0000-0002-4124-1586 | en_US |
dc.contributor.author | Günendi, Zafer | |
dc.contributor.author | Yurdakul, Fatma Gül | |
dc.contributor.author | Bodur, Hatice | |
dc.contributor.author | Cengiz, Ahmet Kıvanç | |
dc.contributor.author | Uçar, Ülkü Gürbüz | |
dc.contributor.author | Çay, Hasan Fatih | |
dc.contributor.author | Şen, Nesrin | |
dc.contributor.author | Keskin, Yaşar | |
dc.contributor.author | Gürer, Gülcan | |
dc.contributor.author | Melikoǧlu, Meltem Alkan | |
dc.contributor.author | Altıntaş, Duygu | |
dc.contributor.author | Deveci, Hülya Mutlu | |
dc.contributor.author | Baykul, Merve | |
dc.contributor.author | Nas, Kemal | |
dc.contributor.author | Çevik, Remzi | |
dc.contributor.author | Karahan, Ali Yavuz | |
dc.contributor.author | Toprak, Murat M. | |
dc.contributor.author | Ketenci, Sertaç | |
dc.contributor.author | Nayimoğlu, Mehmet | |
dc.contributor.author | Sezer, İlhan | |
dc.contributor.author | Demir, Ali Nail | |
dc.contributor.author | Ecesoy, Hilal | |
dc.contributor.author | Duruöz, Tuncay | |
dc.contributor.author | Volkan Yurdakul, Ozan | |
dc.contributor.author | Sarıfakıoğlu, Ayşe Banu | |
dc.contributor.author | Ataman, Şebnem | |
dc.date.accessioned | 2022-05-06T11:28:59Z | |
dc.date.available | 2022-05-06T11:28:59Z | |
dc.date.issued | 2021 | en_US |
dc.department | Dicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Fizik Tedavi ve Rehabilitasyon Ana Bilim Dalı | en_US |
dc.description | PMID: 34032894 | |
dc.description | WOS:000654089100002 | |
dc.description.abstract | The study aimed to evaluate the impact of the coronavirus disease 2019 (COVID-19) in patients with familial Mediterranean fever (FMF) and to assess the relationships between FMF characteristics and severe COVID-19 outcomes such as hospitalization. The study was planned within a national network of 21 different centers. Demographics, FMF-related clinical and genetic characteristics, and COVID-19 outcomes were obtained. A total of 822 patients with FMF (mean age of 36 years) were included in the study. Fifty-nine of them (7%) had a COVID-19 diagnosis confirmed by real-time PCR test or chest CT findings. Most FMF patients with COVID-19 (58) had mild and moderate disease activity. All patients were on colchicine treatment. However, 8 of them (13.6%) were not compliant with colchicine use and 9 of them (15.3%) were colchicine resistant. Twelve FMF patients with COVID-19 were hospitalized. There were 4 patients requiring oxygen support. COVID-19 related complications were observed in 2 patients (1 thromboembolism, 1 acute respiratory distress syndrome). Hospitalized COVID-19 patients with FMF were older than non-hospitalized patients (median ages: 51 and 31 years, respectively; p: 0.002). Other FMF-related characteristics were similar between the groups. FMF-related characteristics were not found to be associated with poor outcomes in COVID-19. Thus, FMF may not be a risk factor for poor COVID-19 outcomes. | en_US |
dc.identifier.citation | Günendi, Z., Yurdakul, F. G., Bodur, H., Cengiz, A. K., Uçar, Ü. G., Çay, H. F. ve diğerleri (2021). The impact of COVID-19 on familial Mediterranean fever: a nationwide study. Rheumatology International, 41(8), 1447-1455. | en_US |
dc.identifier.doi | 10.1007/s00296-021-04892-6 | |
dc.identifier.endpage | 1455 | en_US |
dc.identifier.issn | 0172-8172 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 34032894 | |
dc.identifier.scopus | 2-s2.0-85106463983 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 1447 | en_US |
dc.identifier.uri | https://link.springer.com/article/10.1007/s00296-021-04892-6 | |
dc.identifier.uri | https://hdl.handle.net/11468/9804 | |
dc.identifier.volume | 41 | en_US |
dc.identifier.wos | WOS:000654089100002 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Çevik, Remzi | |
dc.language.iso | tr | en_US |
dc.publisher | Springer Science and Business Media Deutschland GmbH | en_US |
dc.relation.ispartof | Rheumatology International | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Colchicine | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Familial Mediterranean fever | en_US |
dc.subject | Hospitalization | en_US |
dc.subject | Poor outcomes | en_US |
dc.subject | Rheumatic diseases | en_US |
dc.title | The impact of COVID-19 on familial Mediterranean fever: a nationwide study | en_US |
dc.title | The impact of COVID-19 on familial Mediterranean fever: a nationwide study | |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- The impact of COVID-19 on familial Mediterranean fever_ a nationwide study _ Enhanced Reader.pdf
- Boyut:
- 4.95 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Makale Dosyası
Lisans paketi
1 - 1 / 1
[ X ]
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: